Men's Health
Saw Palmetto and Prostate Health: What Trials Have Found
A plain-language look at what clinical research actually shows about saw palmetto, urinary symptoms, and prostate health.

Saw palmetto is one of the most commonly purchased botanical supplements among men in the United States, largely because of its reputation for easing urinary symptoms linked to an enlarged prostate. The clinical picture, however, is more complicated than many product labels suggest, and the strength of evidence varies considerably depending on the specific claim being made.
What Is Saw Palmetto?
Saw palmetto (Serenoa repens) is a small palm native to the southeastern United States. The supplement is typically prepared as a fatty-acid and sterol extract from the plant's berries. Researchers have proposed that these compounds may influence androgen-related pathways in prostate tissue, though the National Institutes of Health notes that any clinical benefit from this mechanism has not been established. No adult daily target intake and no established upper limit exist for saw palmetto, according to NIH Office of Dietary Supplements data.
Saw palmetto is marketed, though not proven, for urinary symptoms associated with benign prostatic hyperplasia (BPH), an enlarged prostate. It is also promoted for male-pattern hair loss and chronic prostatitis/chronic pelvic pain syndrome. These statements have not been evaluated by the FDA, and supplements are not intended to diagnose, treat, cure, or prevent any disease.
What the Evidence Actually Shows
Not all health claims carry the same weight of research behind them. The NIH grades evidence for saw palmetto across several areas, and the ratings differ substantially from one use to another.
BPH and Urinary Symptoms: Strong Evidence Against Benefit
This is the area where the most rigorous research exists, and the conclusion may surprise people who have read enthusiastic product descriptions. According to NIH and the National Center for Complementary and Integrative Health (NCCIH), the evidence is graded strong that saw palmetto used alone does not improve urinary tract symptoms of BPH beyond placebo. Large, well-designed randomized controlled trials, including trials that tested doses higher than those typically sold in stores, found no meaningful difference between saw palmetto and placebo for reducing urinary frequency, improving flow rate, or relieving other lower urinary tract symptoms. This is one of the clearest findings in the botanical supplement literature.
PSA Levels and Prostate Cancer Screening: Moderate Evidence
One concern sometimes raised about supplements that affect androgen pathways is whether they might interfere with prostate-specific antigen (PSA) testing, a key screening tool for prostate cancer. Here the evidence is reassuring. NCCIH reports moderate evidence that saw palmetto does not affect PSA levels or mask prostate cancer screening results, even when taken at higher-than-usual amounts. This is an important practical point: unlike the prescription drug finasteride, saw palmetto does not appear to suppress PSA readings, so it should not distort that lab value. Men using saw palmetto can therefore proceed with routine PSA screening without adjusting for a supplement effect.
Combination Formulas for BPH: Limited Evidence
Some products combine saw palmetto with other ingredients such as lycopene, selenium, or the prescription alpha-blocker tamsulosin. The evidence that these combinations help BPH or lower urinary tract symptoms is graded limited, meaning a small number of studies show some signal but the data are not sufficient to draw firm conclusions. If you are currently prescribed tamsulosin or any other medication for BPH, speak with your doctor before adding any supplement to your routine.
Chronic Prostatitis and Pelvic Pain: Insufficient Evidence
Chronic prostatitis and chronic pelvic pain syndrome are conditions that can be difficult to treat and that significantly affect quality of life. Some men turn to saw palmetto hoping it may help. Unfortunately, the evidence here is graded insufficient, meaning there is simply not enough quality research to draw any conclusions about whether saw palmetto relieves these symptoms.
Male-Pattern Hair Loss: Insufficient Evidence
Saw palmetto is also promoted for androgenetic alopecia, commonly called male-pattern hair loss, based on the theory that it may influence the same hormonal pathway targeted by some hair-loss medications. The evidence for this use is also graded insufficient. A small number of preliminary studies exist, but they do not provide enough data to support a recommendation.
Safety and Tolerability
NCCIH reports that saw palmetto is generally well tolerated, with mild and infrequent adverse effects that include digestive upset, dizziness, and headache. It has been used in research studies for up to three years without significant safety signals emerging in adult men.
There are important populations for whom caution is warranted. Saw palmetto may be unsafe during pregnancy or breastfeeding, and very little is known about its safety in women or children. People in these groups should avoid it unless a clinician specifically advises otherwise.
Because saw palmetto is theorized to affect androgen-related pathways, it is reasonable to exercise caution if you are already taking 5-alpha-reductase inhibitors or other hormone-related drugs, even though no clinically confirmed drug interaction has been documented by NIH. NCCIH states that saw palmetto has not been shown to interact with medications in well-documented studies, but data remain limited. As with any supplement, tell your clinician and pharmacist that you are taking it, particularly before any surgical procedure or if you have concerns about bleeding risk.
Practical Takeaways
- The strongest available evidence suggests saw palmetto used alone does not meaningfully reduce BPH-related urinary symptoms compared to placebo.
- Saw palmetto does not appear to suppress PSA readings, so it should not interfere with routine prostate cancer screening.
- Evidence for combination formulas, chronic prostatitis, and hair loss ranges from limited to insufficient.
- The supplement is generally well tolerated in adult men for up to three years in study settings, but safety data for women, children, and pregnant people are lacking.
- No standardized daily target or upper limit has been established by the NIH Office of Dietary Supplements.
- Always consult a clinician or pharmacist for personal dosing guidance and before combining any supplement with prescription medication.
The Bottom Line
Saw palmetto has been studied more thoroughly than many botanical supplements, and that research has largely not confirmed the benefits that marketing materials often imply. Men experiencing urinary symptoms or other prostate-related concerns should discuss evidence-based options with a urologist or primary care provider rather than relying on supplement use alone. Knowing what the trials actually found is a useful starting point for that conversation.
Sources
- S1.gov verifiedNIH National Center for Complementary and Integrative Health (NCCIH)Saw Palmetto: Usefulness and Safetywww.nccih.nih.gov/health/saw-palmetto
- S2.gov verifiedNIH National Center for Complementary and Integrative Health (NCCIH)Spotlight on Saw Palmetto: What the Science Says (NCCIH Clinical Digest, for health professionals)www.nccih.nih.gov/health/providers/digest/spotlight-
- S3.gov verifiedCochrane Database of Systematic ReviewsFranco JV, et al. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement. 2023;6(6):CD001423pmc.ncbi.nlm.nih.gov/articles/PMC10286776/
- S4.gov verifiedNIH Office of Dietary Supplements (ODS)Note: ODS publishes no Saw Palmetto fact sheet and no Dietary Reference Intake (DRI) exists for this botanical; ODS refers to NCCIH for herbal supplement informationods.od.nih.gov/factsheets/list-all/